Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced its next-generation balloon-expandable valve has received approval from the FDA ...

Please provide your email address to receive an email when new articles are posted on . During the past decade, the options for practitioners of transcatheter aortic valve replacement have expanded on ...

Chief Executive Officer Wayne Paterson outlined the company’s DurAVR transcatheter aortic valve replacement (TAVR) program ...

CHICAGO, IL—For a patient with a large aortic annulus undergoing transcatheter aortic valve replacement, a new study suggests there are different risks and benefits when it comes to the use of ...

A first-ever randomized head-to-head comparison of two devices commonly used to treat the age-related disease aortic stenosis finds balloon-expandable transcatheter valves result in more successful ...

BOSTON, MA—Compared with balloon-expandable bioprosthetic aortic valves, self-expanding devices show superior hemodynamic performance at 1 year in patients with small annuli undergoing TAVI, according ...

Balloon valvuloplasty is used to treat aortic valve stenosis (narrowing). This condition may be congenital, or it may develop later in life as a result of rheumatic fever or calcium build-up on the ...

Evidence for device fracturability under routine balloon inflation with modest pressures ...

The paper by Fratz et al. describes the follow-up of 188 children who had balloon aortic valvuloplasty (AoVP) between 1986 and 2004. Moderate or severe aortic regurgitation occurred more often in the ...